Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Overview of attention for article published in BMC Cancer, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

peer_reviews: 1 peer review site

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 23 Mendeley

Summary Peer reviews Dimensions citations

So far, Dimensions has found 30 publications that cite this research output.

30

The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.

Cryptotanshinone inhibits PFK-mediated aerobic glycolysis by activating AMPK pathway leading to blockade of cutaneous melanoma

Article in Chinese Medicine (March 2024)

Natural products targeting macroautophagy signaling in hepatocellular carcinoma therapy: Recent evidence and perspectives

Article in Phytotherapy Research (February 2024)

“In-silico Design and Development of Novel Hydroxyurea Lipid Drug Conjugates for Breast Cancer Therapy Targeting PI3K/AKT/mTOR Pathway”

Article in Drug Research (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.